pharma · Acute Myeloid Leukemia · Breast Cancer
First People's Hospital
The First People's Hospital of Lianyungang
First People's Hospital is a pharma organization headquartered in SAN DIEGO, CA, CN. Primary therapeutic focus areas include Acute Myeloid Leukemia, Breast Cancer, Gastric Cancer, Multiple Myeloma, Esophageal Squamous Ce
SAN DIEGO, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- SAN DIEGO, CA, CN
- Programs
- 1136
- Drugs
- 626
- Patents
- 123
Obinutuzumab
Unknown · small molecule · Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Obinutuzumab for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma is a Unknown program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).
Internal code GZL
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- The First People's Hospital of Lianyungang
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- active
- Trials
- 1